Graham D. Thomas

3.9k total citations · 1 hit paper
28 papers, 2.6k citations indexed

About

Graham D. Thomas is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Graham D. Thomas has authored 28 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Graham D. Thomas's work include Immune cells in cancer (18 papers), Immune Cell Function and Interaction (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Graham D. Thomas is often cited by papers focused on Immune cells in cancer (18 papers), Immune Cell Function and Interaction (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Graham D. Thomas collaborates with scholars based in United States, United Kingdom and France. Graham D. Thomas's co-authors include Shahram Salek‐Ardakani, Catherine C. Hedrick, Natalija Budimir, Joseph S. Dolina, Richard N. Hanna, Robert Tacke, Paola Marcovecchio, Judith E. Allen, Dominik Rückerl and Amy Blatchley and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Blood.

In The Last Decade

Graham D. Thomas

28 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD8+ T Cell Exhaustion in Cancer

2021 297 citations Joseph S. Dolina, Natalija Budimir et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Graham D. Thomas

Since Specialization

Citations

This map shows the geographic impact of Graham D. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham D. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham D. Thomas more than expected).

Fields of papers citing papers by Graham D. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham D. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham D. Thomas. The network helps show where Graham D. Thomas may publish in the future.

Co-authorship network of co-authors of Graham D. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Graham D. Thomas. A scholar is included among the top collaborators of Graham D. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham D. Thomas. Graham D. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combinatorial immunotherapy induces tumor-infiltrating CD8⁺ T cells with distinct functional, migratory, and stem-like properties 2021 ·Journal for ImmunoTherapy of Cancer ·Natalija Budimir, Joseph S. Dolina, Jie Wei, Xiao Wang, (unknown), Pamela Santiago, (unknown), Luca Micci, Amir A. Al-Khami, Sophia X. Pfister, Sripad Ram, Purnima Sundar, Graham D. Thomas, Hua Long, Wenjing Yang, Shobha Potluri, Shahram Salek‐Ardakani	16
2	EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells 2021 ·Frontiers in Immunology ·Christopher J. Stairiker, Sophia X. Pfister, (unknown), Wenjing Yang, Tao Xie, Catherine Lee, Haikuo Zhang, Christopher P. Dillon, Graham D. Thomas, Shahram Salek‐Ardakani	2
3	CD8+ T Cell Exhaustion in Cancer breakdown → 2021 ·Frontiers in Immunology ·Joseph S. Dolina, Natalija Budimir, Graham D. Thomas, Shahram Salek‐Ardakani	297
4	Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment 2021 ·Frontiers in Oncology ·Graham D. Thomas, Luca Micci, Wenjing Yang, (unknown), Cecilia Oderup, Purnima Sundar, Xiao Wang, Kenneth G. Geles, Shobha Potluri, Shahram Salek‐Ardakani	15
5	Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade 2021 ·Cancer Immunology Research ·Natalija Budimir, Graham D. Thomas, Joseph S. Dolina, Shahram Salek‐Ardakani	171
6	Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment 2020 ·Cell Reports ·Yan Qu, Ji Wen, Graham D. Thomas, Wenjing Yang, (unknown), Wenqian He, Purnima Sundar, Xiao Wang, Shobha Potluri, Shahram Salek‐Ardakani	47
7	EZH2 as a Regulator of CD8+ T Cell Fate and Function 2020 ·Frontiers in Immunology ·Christopher J. Stairiker, Graham D. Thomas, Shahram Salek‐Ardakani	31
8	Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry 2018 ·Arteriosclerosis Thrombosis and Vascular Biology ·Anouk A.J. Hamers, Huy Q. Dinh, Graham D. Thomas, Paola Marcovecchio, Amy Blatchley, Catherine Nakao, Cheryl Kim, Chantel McSkimming, Angela M. Taylor, (unknown), Coleen A. McNamara, Catherine C. Hedrick	126
9	Human Blood Monocyte Subsets 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Graham D. Thomas, Anouk A.J. Hamers, Catherine Nakao, Paola Marcovecchio, Angela M. Taylor, Chantel McSkimming, (unknown), Coleen A. McNamara, Catherine C. Hedrick	132
10	Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Paola Marcovecchio, Graham D. Thomas, Zbigniew Mikulski, Erik Ehinger, Karin Anne Lydia Mueller, Amy Blatchley, Runpei Wu, Yury I. Miller, (unknown), Angela M. Taylor, Coleen A. McNamara, Klaus Ley, Catherine C. Hedrick	66
11	Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6C low Monocytes while Preserving Macrophage Gene Function 2016 ·Immunity ·Graham D. Thomas, Richard N. Hanna, (unknown), Anouk A.J. Hamers, Casey E. Romanoski, Sara McArdle, Kevin D. Ross, Amy Blatchley, (unknown), Bruce A. Hamilton, Zbigniew Mikulski, Mukesh K. Jain, Christopher K. Glass, Catherine C. Hedrick	110
12	2014 Jeffrey M. Hoeg Award Lecture 2016 ·Arteriosclerosis Thrombosis and Vascular Biology ·Yanfang Peipei Zhu, Graham D. Thomas, Catherine C. Hedrick	50
13	Patrolling monocytes control tumor metastasis to the lung 2015 ·Science ·Richard N. Hanna, Caglar Cekic, Duygu Sağ, Robert Tacke, Graham D. Thomas, Heba Nowyhed, (unknown), (unknown), Sara McArdle, Runpei Wu, (unknown), Daniel Metzger, Hiroshi Ichinose, Iftach Shaked, Grzegorz Chodaczek, Subhra K. Biswas, Catherine C. Hedrick	336
14	The Nuclear Receptor Nr4a1 Controls CD8 T Cell Development Through Transcriptional Suppression of Runx3 2015 ·Scientific Reports ·Heba Nowyhed, (unknown), Amy Blatchley, Runpei Wu, Graham D. Thomas, Catherine C. Hedrick	29
15	Nonclassical Patrolling Monocyte Function in the Vasculature 2015 ·Arteriosclerosis Thrombosis and Vascular Biology ·Graham D. Thomas, Robert Tacke, Catherine C. Hedrick, Richard N. Hanna	249
16	Phylogenomics and Analysis of Shared Genes Suggest a Single Transition to Mutualism in Wolbachia of Nematodes 2013 ·Genome Biology and Evolution ·Francesco Comandatore, Davide Sassera, Matteo Montagna, Sujai Kumar, Georgios Koutsovoulos, Graham D. Thomas, (unknown), Simon A. Babayan, Nicholas A. Gray, Richard Cordaux, Alistair C. Darby, Benjamin L. Makepeace, Mark Blaxter	40
17	IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1 2013 ·The Journal of Experimental Medicine ·Stephen J. Jenkins, Dominik Rückerl, Graham D. Thomas, James P. Hewitson, Sheelagh Duncan, Frank Brombacher, Rick M. Maizels, David Hume, Judith E. Allen	312
18	Local Amplification of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes 2006 ·The Journal of Immunology ·James S. Gilmour, Agnes E. Coutinho, Jean‐François Cailhier, Tak Yung Man, Michael Clay, Graham D. Thomas, Hayley J. Harris, John J. Mullins, Jonathan R. Seckl, John Savill, Karen E. Chapman	119
19	Apoptosis and Myofibroblast Expression in Human Glomerular Disease: A Possible Link with Transforming Growth Factor-Beta-1 2002 ·The Nephron journals/Nephron journals ·Dimitrios Goumenos, Athanassios C. Tsamandas, A. Meguid El Nahas, Graham D. Thomas, Sotiris Tsakas, (unknown), Dionysis S. Bonikos, John G. Vlachojannis	15
20	Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation 2002 ·Journal of the American Society of Nephrology ·Siobhán Mitchell, Graham D. Thomas, (unknown), David C. Cottell, (unknown), (unknown), Nicos A. Petasis, Lars P. Erwig, Andrew J. Rees, John Savill, Hugh R. Brady, Catherine Godson	237

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact